Dr. Eric H. Liu, Director of the Neuroendocrine Center and Director of Surgical Services at Vanderbilt University Medical Center in Tennessee, presented a live webinar on August 22, 2012 entitled Imaging of Neuroendocrine Tumors and Obstacles to Diagnosis. The archived webinar is now available for those who registered but were unable to join the live event and for everyone who would like to see it again or for the first time. Click here to access the webinar. First-time viewers need to create an account; click Enroll Now on the left-hand column to register for the webinar.
Eric H. Liu, MD
The webinar covers the array of symptoms by which neuroendocrine tumors (NETs) can present, the multiple locations where they can occur, and the diagnostic tools necessary to confirm the presence of NETs. There are an increasing number of new treatment modalities that may result in a better quality of life and longer survival of NETs patients. Dr. Liu talks about the critical role diagnostic imaging plays in the assessment of NETs and in monitoring response to therapy.
Dr. Liu was recruited to Vanderbilt in 2009 to develop the Neuroendocrine Center, after studying with renowned neuroendocrine surgeon Kjell Oberg, MD, PhD, in Sweden, who was perfecting the use of radioactive imaging tracers that offered patients new treatment options. Under Dr. Liu’s direction, the Vanderbilt Neuroendocrine Center consists of a coalition of scientists and clinicians working together to provide patients with the most innovative and comprehensive diagnostic tools, as well as treatment therapies that provide the best possible patient outcomes.
Dr. Kjell Oberg from Uppsala University in Sweden (left) and Dr. Eric H. Liu from Vanderbilt University (right)
Dr. Liu’s clinical interests include all aspects of surgical oncology and endocrine surgery with an emphasis on the treatment of neuroendocrine and carcinoid tumors, gastrointestinal, and endocrine diseases He actively engages in research, developing new biomarkers and imaging techniques for better diagnosis of neuroendocrine tumors. In 2011 he was elected to the Board of Directors of the North American Neuroendocrine Tumor Society (NANETS), the professional organization created to improve neuroendocrine tumor (NET) disease management through increased research and educational opportunities.
The webinar is jointly sponsored by Postgraduate Institute for Medicine International Center for Postgraduate Medical Education and NANETS, the North American Neuroendocrine Tumor Society. It is designed for radiologists, oncologists, gastroenterologists, endocrinologists, and other healthcare providers who diagnose and treat patients with NETs. CME credit is available.
For questions or assistance accessing the webinar, please contact ICPME at 607-257-5860, ext. 10 or by email at information@icpmed.com.
